BEIJING — Parkinson’s disease ... allowing for targeted treatment without affecting surrounding areas. Safety tests showed promising results. The nanoparticles stayed where they were supposed ...

The symptoms of Parkinson's disease could be reversed through injections of nanoparticles into the brain, which is a much less invasive procedure than existing treatments. It could reduce side ...

CHEN Chunying from the National Center for Nanoscience and Technology (NCNST) of the Chinese Academy of Sciences (1 Trusted Source A nanoparticle ... treatments for Parkinson's disease ...

Parkinson's disease (PD) is the second most common neurodegenerative ... transcranial direct current stimulation and transcranial magnetic stimulation can enhance cortical excitability but are ...

From a study that analyzed brain images of more than 2,500 people with Parkinson's disease in 20 different countries, ...

Parkinson's disease ... The administered nanoparticles were safely expelled into the cerebrospinal fluid within 8 weeks without leaving the treatment area, and no toxicity was observed.

Clinical studies have revealed that rasagiline is associated with improved outcomes in patients with early Parkinson's disease (PD ... may be more prone to treatment-emergent adverse ...

The FDA has approved Onapgo, the first subcutaneous apomorphine device to treat motor fluctuations in adults with Parkinson’s disease, according to the manufacturer.In a press release, Supernus ...